ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

CE

Centre Eugène Marquis at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Centre Eugène Marquis takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions focus on first-line treatment and quality of life in HER2-positive metastatic breast cancer. They examine real-world outcomes with pertuzumab-based treatment and quality of life during a trial of tucatinib with other cancer drugs.

OrganizationESMO 2026 Attendance
CE
Centre Eugène Marquis
Rennes, France
Cancer centre & hospital
Comprehensive cancer centre in Rennes, France, part of the Unicancer network of French cancer centres.
Satellite
Sun Oct 25
13:05–13:20
Paradigm Shift: The First Changes in First-Line Treatment for HER2-Positive mBC in a Decade
Answers in CME - Building a Bridge From Evidence to Practice: Case Discussion of First-Line Treatment of HER2‑Positive mBC · with University Hospital Erlangen, University of Washington
Breast cancer
Satellite
Sun Oct 25
13:20–13:35
Supporting Evidence: The Data Driving Updates to the First-Line Standard of Care for HER2-Positive mBC
Answers in CME - Building a Bridge From Evidence to Practice: Case Discussion of First-Line Treatment of HER2‑Positive mBC · with University Hospital Erlangen, University of Washington
Breast cancer
Satellite
Sun Oct 25
13:35–13:50
Patient Selection: Identifying Candidates for Novel First-Line Regimens for HER2-Positive mBC
Answers in CME - Building a Bridge From Evidence to Practice: Case Discussion of First-Line Treatment of HER2‑Positive mBC · with University Hospital Erlangen, University of Washington
Breast cancer
Satellite
Sun Oct 25
13:50–14:05
Practical Implementation: Managing Care for Patients on First-Line Regimens for HER2- Positive mBC
Answers in CME - Building a Bridge From Evidence to Practice: Case Discussion of First-Line Treatment of HER2‑Positive mBC · with University Hospital Erlangen, University of Washington
Breast cancer
Satellite
Sun Oct 25
14:05–14:30
Questions, Take-Home Learnings, and Evaluation
Answers in CME - Building a Bridge From Evidence to Practice: Case Discussion of First-Line Treatment of HER2‑Positive mBC · with University Hospital Erlangen, University of Washington
Breast cancer

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Centre Eugène Marquis

Tell us what you sell and we’ll find the people at Centre Eugène Marquis most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction